Bristol Myers Squibb (BMY) Common Equity (2009 - 2026)
Bristol Myers Squibb's Common Equity came in at $22.32 billion for Q2 2026, up 27.6% from $17.49 billion a year earlier and up 11.0% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb's Common Equity was $18.51 billion, up 12.9% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $16.39 billion in FY2024 (-44.4%), $29.49 billion in FY2023 (-5.2%), $31.12 billion in FY2022 (-13.6%) and $36.01 billion in FY2021 (-5.0%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q4 2023.
- Year-over-year, Common Equity has increased for six consecutive quarters, with an average decline of 1.7% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 27.6%), and the weakest in Q1 2024 (a decline of 48.1%).
- Business Quant data shows BMY's Common Equity at $20.1 billion (Q1 2026), $18.51 billion (Q4 2025) and $18.6 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.65 Bn | 1,122.23 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 623.91 Bn | 542.44 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 511.45 Bn | 484.57 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 365.35 Bn | 319.73 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.16 Bn | 261.15 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.20 Bn | 234.89 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 234.89 Bn | 190.29 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 193.02 Bn | 167.22 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.60 Bn | 118.24 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Bristol Myers Squibb | 125.45 Bn | 76.72 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.32 Bn |
| Mar 31, 2026 | 20.10 Bn |
| Dec 31, 2025 | 18.51 Bn |
| Sep 30, 2025 | 18.60 Bn |
| Jun 30, 2025 | 17.49 Bn |
| Mar 31, 2025 | 17.45 Bn |
| Dec 31, 2024 | 16.39 Bn |
| Sep 30, 2024 | 17.20 Bn |
| Jun 30, 2024 | 17.07 Bn |
| Mar 31, 2024 | 16.55 Bn |
| Dec 31, 2023 | 29.49 Bn |
| Sep 30, 2023 | 29.06 Bn |
| Jun 30, 2023 | 32.03 Bn |
| Mar 31, 2023 | 31.89 Bn |
| Dec 31, 2022 | 31.12 Bn |
| Sep 30, 2022 | 32.73 Bn |
| Jun 30, 2022 | 32.66 Bn |
| Mar 31, 2022 | 31.65 Bn |
| Dec 31, 2021 | 36.01 Bn |
| Sep 30, 2021 | 37.28 Bn |
API Access
Bristol Myers Squibb Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();